Okay. All right. Let's get started with the next session of Citi's Global Healthcare Conference. It's my great pleasure to have with me the senior management of Incyte Corporation. We have the CEO, ...

Incyte (INCY) shares have shown solid momentum over the past month, gaining 12% and delivering a 21% return over the past 3 months. The company continues to draw investor attention for its performance ...

Incyte Corporation is undervalued, with high revenue growth, strong margins, and a 12.7% upside to a $115 target price; rated Buy. INCY's Q3 results beat expectations, driven by Jakafi and Opzelura ...

Abstract: Multi-view clustering aims to learn discriminative representations from multi-view data. Although existing methods show impressive performance by leveraging contrastive learning to tackle ...